HNB
KRTX

Huntington National Bank’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Huntington National Bank’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-38,411
Closed -$12.2M – 4043
2023
Q4 		$12.2M Buy
38,411
+60
+0.2% +$11.7K 0.11% 169
2023
Q3 		$6.48M Sell
38,351
-18
-0% -$3.38K 0.07% 210
2023
Q2 		$8.32M Buy
38,369
+18
+0% +$3.86K 0.08% 199
2023
Q1 		$6.97M Buy
38,351
+140
+0.4% +$26.8K 0.07% 203
2022
Q4 		$7.51M Hold
38,211
– – 0.08% 195
2022
Q3 		$8.6M Hold
38,211
– – 0.1% 180
2022
Q2 		$4.83M Hold
38,211
– – 0.05% 230
2022
Q1 		$4.84M Hold
38,211
– – 0.04% 240
2021
Q4 		$5.01M Hold
38,211
– – 0.05% 241
2021
Q3 		$4.67M Hold
38,211
– – 0.05% 237
2021
Q2 		$4.36M Hold
38,211
– – 0.04% 239
2021
Q1 		$4.59M Hold
38,211
– – 0.06% 209
2020
Q4 		$3.88M Hold
38,211
– – 0.05% 209
2020
Q3 		$2.95M Buy
+38,211
New +$3.26M 0.04% 221

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Huntington National Bank's KRTX Position: Q1 2024 in Review

Huntington National Bank sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 38,411 shares — an estimated $12.2M sold.

Huntington National Bank first reported a position in KRTX in Q3 2020 and held it in 14 quarters. The position peaked at $12.2M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Huntington National Bank reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Huntington National Bank sold 38,411 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $12.2M.
  • Huntington National Bank first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2020 and held it in 14 quarters.
  • Huntington National Bank's Karuna Therapeutics, Inc. Common Stock position peaked at $12.2M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Huntington National Bank's 13F filing for Q1 2024, filed 3 May 2024.